Osage University Partners

Osage University Partners is a U.S. venture firm that invests exclusively in companies built around technology developed at partner universities, with a healthcare practice focused on biotech and medical devices and medtech. The firm has formal relationships with a network of research institutions and works alongside university technology transfer offices and founding scientists to back companies commercializing academic innovations. This structural focus means it routinely engages with deep-science and deep-engineering companies whose competitive advantage comes from underlying intellectual property and scientific rigor. Specific portfolio names and individual partner detail are not provided in the input, so the profile emphasizes the firm’s institutional model.

Osage writes checks of $5M to $25M and invests across Seed, Series A, Series B, and Series C stages from its base in Bala Cynwyd, Pennsylvania. Its multi-stage posture allows it to enter early when university technology is first being commercialized and continue supporting companies as they advance through clinical or product milestones. The firm operates primarily in the United States.

For founders, Osage is most relevant when the company is built on technology licensed from a research institution, particularly within its university partner network. The firm’s diligence is rigorous on the science, IP position, and the alignment between founders, institution, and investors. Founders should expect a partner that understands the dynamics of academic spinouts, including licensing structures, founding-scientist roles, and the long arcs typical of biotech and medtech development, and a team that engages directly on building the company beyond the initial technology.